H. Büller
Internal Medicine · 2000–2017
A researcher in the Science corpus: 14 papers; trusts 1 researcher and is trusted by 0 researchers here, as inferred from the citation graph.
Subfields
- Internal Medicine — 101 citations into it
Whom H. Büller trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Who trusts H. Büller overall
Papers from H. Büller's perspective
Ordered by how strongly the researchers H. Büller trusts endorse each paper. Same corpus, a different order for every researcher.
- Fibrinolysis for patients with intermediate-risk pulmonary embolism. (New England Journal of Medicine)
- Simplification of the pulmonary embolism severity index for prognostication in patients with acute symptomatic pulmonary embolism. (Archives of Internal Medicine)
- Multidetector computed tomography for acute pulmonary embolism. (New England Journal of Medicine)
- Randomized, Controlled Trial of Ultrasound-Assisted Catheter-Directed Thrombolysis for Acute Intermediate-Risk Pulmonary Embolism (Circulation)
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. (The Lancet)
- Development and validation of a predictive model for chemotherapy-associated thrombosis. (Blood)
- Derivation of a Simple Clinical Model to Categorize Patients Probability of Pulmonary Embolism: Increasing the Models Utility with the SimpliRED D-dimer
- Excluding Pulmonary Embolism at the Bedside without Diagnostic Imaging: Management of Patients with Suspected Pulmonary Embolism Presenting to the Emergency Department by Using a Simple Clinical… (Annals of Internal Medicine)
- Ventilation–Perfusion Scintigraphy Is More Sensitive than Multidetector CTPA in Detecting Chronic Thromboembolic Pulmonary Disease as a Treatable Cause of Pulmonary Hypertension (Journal of Nuclear Medicine)
- Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry. (Journal of Thoracic and Cardiovascular Surgery)
Their papers
- Edoxaban for the Treatment of Cancer‐Associated Venous Thromboembolism (2017) — 874 citations
- Thrombosis: A Major Contributor to Global Disease Burden (2014) — 635 citations
- Direct oral anticoagulants compared with vitamin K antagonists for acute venous thromboembolism: evidence from phase 3 trials. (2014) — 801 citations
- [2014 ESC Guidelines on the diagnosis and management of acute pulmonary embolism]. (2014) — 760 citations
- Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism. (2013) — 1,829 citations
- International clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer (2013) — 711 citations
- Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. (2012) — 1,719 citations
- Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE‐MODEL randomized trial (2007) — 1,051 citations
- Dabigatran etexilate versus enoxaparin for prevention of venous thromboembolism after total hip replacement: a randomised, double-blind, non-inferiority trial. (2007) — 1,166 citations
- Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography. (2006) — 1,123 citations
- The effect of low molecular weight heparin on survival in patients with advanced malignancy. (2005) — 639 citations
- Bidirectional Relation Between Inflammation and Coagulation (2004) — 927 citations
- Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. (2004) — 1,347 citations
- Incidence of recurrent thromboembolic and bleeding complications among patients with venous thromboembolism in relation to both malignancy and achieved international normalized ratio: a retrospective analysis. (2000) — 768 citations